Finerenone in Black Patients With Type 2 Diabetes and CKD: A Post hoc Analysis of the Pooled FIDELIO-DKD and FIGARO-DKD Trials

Finerenone in Black Patients With Type 2 Diabetes and CKD: A Post hoc Analysis of the Pooled FIDELIO-DKD and FIGARO-DKD Trials

Rationale & Objective: In FIDELITY, finerenone improved cardiorenal outcomes in patients with chronic kidney disease (CKD) and type 2 diabetes (T2D). This analysis explored the efficacy and safety of finerenone in Black patients. Study Design: Subanalysis of randomized controlled trials. Set...

Full description

Bibliographic Details
Main Authors: John M. Flack, Rajiv Agarwal, Stefan D. Anker, Bertram Pitt, Luis M. Ruilope, Peter Rossing, Sharon G. Adler, Linda Fried, Kenneth Jamerson, Robert Toto, Meike Brinker, Alfredo E. Farjat, Peter Kolkhof, Robert Lawatscheck, Amer Joseph, George L. Bakris
Format: Article
Language:English
Published: Elsevier 2023-12-01
Series:Kidney Medicine
Subjects:
Cardiorenal
chronic kidney disease
clinical trial
finerenone
race
type 2 diabetes
Online Access:http://www.sciencedirect.com/science/article/pii/S2590059523001486

Internet

http://www.sciencedirect.com/science/article/pii/S2590059523001486

Similar Items